Recovering Addict Warns 7-OH Truly Destroying Lives, Calls for Stricter Regulations

Why it matters

This personal account from Noah Fisher, a recovering 7-OH user, combined with physician expertise, documents the gap between product labeling and reality—recommended doses of 12-15 mg versus packages containing 100-500 mg pills—and the absence of accessible harm reduction guidance.

The big picture

Fisher's experience illustrates how 7-OH's legal availability in gas stations and vape shops, coupled with misleading dosing information and appealing branding (cherry, blueberry flavors; product names like Dopium), creates a pathway to rapid addiction. Virginia has passed a regulation bill limiting sales to 21+ and requiring full ingredient disclosure, though an outright ban bill failed.

Key findings

• 7-OH is 5-15 times more potent than morphine but sold with minimal oversight at convenience stores and gas stations
• Recommended dose is 12-15 mg; commercial packages contain 100-500 mg pills with little consumer education on appropriate dosing
• Noah Fisher escalated from occasional use to rolling quarters to afford daily doses, experiencing rapid tolerance and opioid-like withdrawal
• Poison center directors nationwide express concern; Dr. John Downs (Virginia Poison Center) stated no peer poison center directors believe 7-OH is appropriate for shelf sales
• Virginia's passed regulation bill restricts sales to 21+ and mandates ingredient disclosure, but fell short of outright ban

What they say

It's bizarre to be able to know that this is legal. That the government is getting tax money off of something that can be taken off the shelves. — Noah Fisher, recovering 7-OH user

Bottom line

A recovering 7-OH user and poison center directors argue that concentrated 7-OH products—sold with dosing guidance contradicted by commercial packaging and marketed with youth-appealing branding—have no place in retail settings without prescription and medical oversight.